Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2007

01-04-2007 | Case Report

Quantification of Circulating Varicella-Zoster Virus DNA for Follow-up in a Case of Visceral Varicella-Zoster Infection Ameliorated with Intravenous Acyclovir

Authors: Jo Ishizawa, Hiroyuki Fujita, Mai Iguchi, Takayoshi Tachibana, Jun Taguchi, Yoshiaki Ishigatsubo

Published in: International Journal of Hematology | Issue 3/2007

Login to get access
Metadata
Title
Quantification of Circulating Varicella-Zoster Virus DNA for Follow-up in a Case of Visceral Varicella-Zoster Infection Ameliorated with Intravenous Acyclovir
Authors
Jo Ishizawa
Hiroyuki Fujita
Mai Iguchi
Takayoshi Tachibana
Jun Taguchi
Yoshiaki Ishigatsubo
Publication date
01-04-2007
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2007
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.06127

Other articles of this Issue 3/2007

International Journal of Hematology 3/2007 Go to the issue

Letter to the Editor

Epstein-Barr Virus Infection after Unrelated Cord Blood Transplantation: Reactivation or Reinfection?

OriginalPaper

Peroxisome Proliferator-Activated Receptor γ and Retinoic Acid Receptor Synergistically Up-Regulate the Tumor Suppressor PTEN in Human Promyeloid Leukemia Cells

Case Report

Reactive Peripheral Blood Plasmacytosis in a Patient with Acute Hepatitis A

Letter to the Editor

Trisomy 21 as the Sole Acquired Karyotypic Abnormality in Biphenotypic Acute Leukemia

Case Report

Successful Treatment of Primary Cardiac Lymphoma by Rituximab-CHOP and High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation

OriginalPaper

Outcome and Prognostic Factors in Patients with Hematologic Malignancies Admitted to the Intensive Care Unit: A Single-Center Experience
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits